These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30328587)

  • 1. Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
    Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
    Drug Saf; 2018 Dec; 41(12):1431-1437. PubMed ID: 30328587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
    Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
    Drug Saf; 2018 Jun; 41(6):625-640. PubMed ID: 29492878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
    Li X; Zhong K; Guo Z; Zhong D; Chen X
    Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Two different therapies for the middle turbinate during endoscopic sinus surgery for chronic rhinosinusitis.
    Zhu M; Yan Y; Gong H; Wu Y; Tan G
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3091-3093. PubMed ID: 32740719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hepatic transcriptome analyses revealed possible pathogenic mechanisms of fasiglifam (TAK-875)-induced acute liver injury in mice.
    Urano Y; Oda S; Tsuneyama K; Yokoi T
    Chem Biol Interact; 2018 Dec; 296():185-197. PubMed ID: 30243991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
    Hutcheson IR; Knowlden JM; Hiscox SE; Barrow D; Gee JMW; Robertson JF; Ellis IO; Nicholson RI
    Breast Cancer Res; 2018 Aug; 20(1):98. PubMed ID: 30165904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corrigendum] TLR4-mediated NF-κB signaling pathway mediates HMGB1-induced pancreatic injury in mice with severe acute pancreatitis.
    Li G; Wu X; Yang L; He Y; Liu Y; Jin X; Yuan H
    Int J Mol Med; 2016 Oct; 38(4):1313. PubMed ID: 27573568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to: The role of melatonin in the onset and progression of type 3 diabetes.
    Song J; Whitcomb DJ; Kim BC
    Mol Brain; 2017 Dec; 10(1):59. PubMed ID: 29221469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2020 Jan; 39(1):21. PubMed ID: 31987045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publisher Correction: Fgf10 is essential for limb and lung formation.
    Sekine K; Ohuchi H; Fujiwara M; Yamasaki M; Yoshizawa T; Sato T; Yagishita N; Matsui D; Koga Y; Itoh N; Kato S
    Nat Genet; 2019 May; 51(5):921. PubMed ID: 30948796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corrigendum] Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
    Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
    Int J Oncol; 2017 Jan; 50(1):340. PubMed ID: 27779677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver Injury.
    Wolenski FS; Zhu AZX; Johnson M; Yu S; Moriya Y; Ebihara T; Csizmadia V; Grieves J; Paton M; Liao M; Gemski C; Pan L; Vakilynejad M; Dragan YP; Chowdhury SK; Kirby PJ
    Toxicol Sci; 2017 May; 157(1):50-61. PubMed ID: 28108665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Characterization of oogonia stem cells in mice by Fragilis.
    Sheng X; Tian C; Liu L; Wang L; Ye X; Li J; Zeng M; Liu L
    Protein Cell; 2020 Dec; 11(12):928-930. PubMed ID: 32583065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance.
    Newbould V; Le Meur S; Goedecke T; Kurz X
    Drug Saf; 2018 Dec; 41(12):1439-1440. PubMed ID: 30027420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.
    Peng XV; Marcinak JF; Raanan MG; Cao C
    Diabetes Obes Metab; 2017 Aug; 19(8):1127-1134. PubMed ID: 28239939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway.
    Gao X; Guo S; Zhang S; Liu A; Shi L; Zhang Y
    J Transl Med; 2019 Aug; 17(1):277. PubMed ID: 31434567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
    Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Dimonaco S; Brockwell L
    Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus.
    Ma J; Li X; Wang Y; Yang Z; Luo J
    Int J Mol Med; 2018 Jun; 41(6):3736. PubMed ID: 29568957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
    Ito R; Tsujihata Y; Suzuki M; Miyawaki K; Matsuda K; Takeuchi K
    J Pharmacol Exp Ther; 2016 Apr; 357(1):217-27. PubMed ID: 26813930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.